<DOC>
	<DOC>NCT02953223</DOC>
	<brief_summary>To assess the frequency and nature of adverse events in infants fed a free amino acid based infant formula.</brief_summary>
	<brief_title>A Study to Monitor the Use of an Amino Acid-Based Infant Formula</brief_title>
	<detailed_description>Prospective, post-market surveillance program to be conducted in the United States (US). Infant will be invited to enroll by their healthcare provider who recommends the use of a free amino acid based infant formula</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<mesh_term>Malabsorption Syndromes</mesh_term>
	<criteria>Infants who use a free amino acid based Infant formula during their first year of life including: Those that are currently consuming the formula at the time of enrollment Those for whom consumption of the formula is planned At least one parent/guardian is willing to provide written informed consent form (ICF) for participation in the surveillance program Infants &lt;37 weeks of corrected gestation age (CGA) at time of enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>